Skip to content
★ Sign in to follow
RF

Robert F. Johnston

Pharmos Corp
Total declarations
23
Company
1
▲ Purchases (16 ops.)
€494k
▼ Sales (2 ops.)
€31k

Latest filing published 30 Mar 2011 for PHARMOS CORP, €232.

Insider track record

Disclosed buys
16
Disclosed sells
2
Signal history

No signal scores available.

Closed purchases

Market purchases
16

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Robert F. Johnston: trading record in brief

Robert F. Johnston is a declared insider of Pharmos Corp, with filings sourced from SEC (Form 4). In total, 23 filings cover trades dated from 5 August 2008 to 28 March 2011.

Market trades split into 16 purchases (€494k) and 2 sales (€31k). On balance, insiders were net buyers of €463k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants. So far in 2011, the count stands at 9 purchases and no sales.

The median purchase comes to €1,710.

On 30 March 2011 came the latest disclosure, an open-market purchase for €232 in Pharmos Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Robert F. Johnston

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations22 total
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    327 USD0SEC
    3,628 shares@ US$0.09common stockSEC:0001422645-11-000009:0
    Canonical exit: 26 Jun 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    810 USD0SEC
    8,999 shares@ US$0.09common stockSEC:0001422645-11-000008:0
    Canonical exit: 21 Jun 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    5,131 USD0SEC
    57,015 shares@ US$0.09common stockSEC:0001422645-11-000006:0
    Canonical exit: 19 Jun 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    7,354 USD0SEC
    81,708 shares@ US$0.09common stockSEC:0001422645-11-000007:0
    Canonical exit: 20 Jun 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    3,862 USD0SEC
    42,910 shares@ US$0.09common stockSEC:0001422645-11-000005:0
    Canonical exit: 6 Jun 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    390 USD0SEC
    4,590 shares@ US$0.085common stockSEC:0001422645-11-000004:0
    Canonical exit: 1 Jun 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    4,699 USD0SEC
    52,500 shares@ US$0.0895common stockSEC:0001422645-11-000003:0
    Canonical exit: 30 May 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    5,400 USD0SEC
    54,000 shares@ US$0.10common stockSEC:0001422645-11-000001:0
    Canonical exit: 29 Mar 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    1,998 USD0SEC
    20,000 shares@ US$0.0999common stockSEC:0001422645-11-000001:1
    Canonical exit: 30 Mar 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    8,119 USD0SEC
    81,190 shares@ US$0.10common stockSEC:0001422645-10-000005:0
    Canonical exit: 23 Mar 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    684 USD0SEC
    6,840 shares@ US$0.10common stockSEC:0001422645-10-000004:0
    Canonical exit: 20 Mar 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    700 USD0SEC
    7,000 shares@ US$0.10common stockSEC:0001422645-10-000004:1
    Canonical exit: 21 Mar 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    497 USD0SEC
    4,970 shares@ US$0.10common stockSEC:0001422645-10-000004:2
    Canonical exit: 22 Mar 2011 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    2,516 USD0SEC
    34,000 shares@ US$0.074common stockSEC:0001422645-10-000003:0
    Canonical exit: 8 Nov 2010 (T+90)
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    1,725 USD0SEC
    23,000 shares@ US$0.075common stockSEC:0001422645-10-000003:1
    Canonical exit: 8 Nov 2010 (T+90)
  • ▼
    Executive ChairmanExecutivesPharmos Corp
    22,470 USD0SEC
    350,000 shares@ US$0.0642common stockSEC:0001422645-10-000001:0
  • ▼
    Executive ChairmanExecutivesPharmos Corp
    14,590 USD0SEC
    244,382 shares@ US$0.0597common stockSEC:0001422645-10-000001:1
  • ●
    Executive ChairmanExecutivesPharmos Corp
    5,382 USD0SEC
    99,660 shares@ US$0.054common stockSEC:0001422645-09-000004:0
  • ◆
    Executive ChairmanExecutivesPharmos Corp
    264,000 USD0SEC
    1,200,000 shares@ US$0.22common stockSEC:0001422645-09-000004:1
  • ●
    Executive ChairmanExecutivesPharmos Corp
    0SEC
    3,715,190 sharescommon stockSEC:0001422645-09-000003:1
  • ▲
    Executive ChairmanExecutivesPharmos Corp
    600,000 USD0SEC
    6,000,000 shares@ US$0.10common stockSEC:0001422645-09-000003:0
    Canonical exit: 20 Jul 2009 (T+90)
  • ●
    Executive ChairmanExecutivesPharmos Corp
    53,201 USD0SEC
    148,605 shares@ US$0.358common stockSEC:0001422645-08-000008:0

22 of 22 declarations